Federated Hermes’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$200K Sell
2,553
-39
-2% -$3.05K ﹤0.01% 1497
2025
Q1
$188K Buy
2,592
+1,456
+128% +$106K ﹤0.01% 1498
2024
Q4
$84.1K Sell
1,136
-2,068
-65% -$153K ﹤0.01% 1589
2024
Q3
$211K Buy
3,204
+1,580
+97% +$104K ﹤0.01% 1471
2024
Q2
$150K Sell
1,624
-201
-11% -$18.6K ﹤0.01% 1519
2024
Q1
$174K Sell
1,825
-178
-9% -$17K ﹤0.01% 1519
2023
Q4
$153K Sell
2,003
-10,491
-84% -$800K ﹤0.01% 1546
2023
Q3
$866K Sell
12,494
-6,879
-36% -$477K ﹤0.01% 1161
2023
Q2
$1.83M Buy
19,373
+6,485
+50% +$612K ﹤0.01% 987
2023
Q1
$1.07M Buy
12,888
+9,016
+233% +$746K ﹤0.01% 1153
2022
Q4
$289K Sell
3,872
-740,680
-99% -$55.3M ﹤0.01% 1494
2022
Q3
$61.5M Buy
744,552
+1,041
+0.1% +$86K 0.18% 141
2022
Q2
$70.7M Sell
743,511
-56,616
-7% -$5.38M 0.19% 138
2022
Q1
$94.2M Sell
800,127
-24,807
-3% -$2.92M 0.21% 129
2021
Q4
$107M Buy
824,934
+866
+0.1% +$112K 0.2% 139
2021
Q3
$93.3M Buy
824,068
+1,623
+0.2% +$184K 0.18% 160
2021
Q2
$85.2M Buy
822,445
+439
+0.1% +$45.5K 0.16% 177
2021
Q1
$68.8M Sell
822,006
-249
-0% -$20.8K 0.13% 201
2020
Q4
$75M Sell
822,255
-403
-0% -$36.8K 0.15% 171
2020
Q3
$65.7M Sell
822,658
-12,012
-1% -$959K 0.15% 157
2020
Q2
$57.7M Sell
834,670
-16,433
-2% -$1.14M 0.14% 163
2020
Q1
$53.5M Sell
851,103
-33,474
-4% -$2.1M 0.16% 148
2019
Q4
$68.8M Buy
884,577
+15,615
+2% +$1.21M 0.15% 156
2019
Q3
$63.7M Sell
868,962
-78,276
-8% -$5.74M 0.16% 150
2019
Q2
$58.3M Sell
947,238
-90,303
-9% -$5.56M 0.14% 160
2019
Q1
$66.2M Sell
1,037,541
-30,615
-3% -$1.95M 0.16% 132
2018
Q4
$54.5M Sell
1,068,156
-937,917
-47% -$47.9M 0.15% 144
2018
Q3
$116M Sell
2,006,073
-116,661
-5% -$6.77M 0.27% 74
2018
Q2
$103M Sell
2,122,734
-302,601
-12% -$14.7M 0.3% 76
2018
Q1
$113M Sell
2,425,335
-95,976
-4% -$4.46M 0.33% 63
2017
Q4
$94.7M Sell
2,521,311
-1,545
-0.1% -$58K 0.27% 74
2017
Q3
$91.9M Buy
2,522,856
+191,763
+8% +$6.99M 0.26% 75
2017
Q2
$91.9M Sell
2,331,093
-17,055
-0.7% -$672K 0.26% 67
2017
Q1
$73.6M Buy
2,348,148
+477,114
+26% +$15M 0.21% 87
2016
Q4
$58.4M Buy
1,871,034
+891,966
+91% +$27.9M 0.18% 113
2016
Q3
$39.3M Sell
979,068
-124,233
-11% -$4.99M 0.11% 142
2016
Q2
$36.7M Buy
1,103,301
+962,562
+684% +$32M 0.11% 151
2016
Q1
$4.14M Buy
140,739
+131,976
+1,506% +$3.88M 0.01% 596
2015
Q4
$230K Sell
8,763
-368,799
-98% -$9.68M ﹤0.01% 1453
2015
Q3
$8.95M Buy
377,562
+237,792
+170% +$5.63M 0.03% 454
2015
Q2
$3.32M Sell
139,770
-150,504
-52% -$3.57M 0.01% 741
2015
Q1
$6.89M Buy
290,274
+36,672
+14% +$871K 0.02% 530
2014
Q4
$5.38M Buy
253,602
+204,330
+415% +$4.34M 0.02% 587
2014
Q3
$839K Buy
49,272
+6,960
+16% +$119K ﹤0.01% 1238
2014
Q2
$605K Buy
42,312
+21,984
+108% +$314K ﹤0.01% 1308
2014
Q1
$251K Buy
20,328
+2,568
+14% +$31.7K ﹤0.01% 1469
2013
Q4
$195K Buy
17,760
+6,954
+64% +$76.4K ﹤0.01% 1487
2013
Q3
$125K Buy
10,806
+9,000
+498% +$104K ﹤0.01% 1529
2013
Q2
$20K Buy
+1,806
New +$20K ﹤0.01% 1652